Search
for
Sort by
Research 151–180 of 1000+
- A Systematic Review of the Effectiveness of Probiotics in the Treatment of Acne Vulgaris since 2020: A Quantitative Study
- Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial
- Tolerance and safety profile of sublingual minoxidil in the treatment of androgenic alopecia
- Abstracts Pt.30
- Antiretroviral nucleoside and nucleotide analogues and mitochondria
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Dutasteride
- Pemphigus Foliaceus in 91 Dogs
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Unilateral Gynecomastia Induced by Treatment With 1 mg of Oral Finasteride
- Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials
- A comment on the post-finasteride syndrome
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Antiandrogenic drugs, a therapeutic option for frontal fibrosing alopecia patients
- Transmasculine Hormone Therapy
- Long-Term Experience With 5-alpha-Reductase Inhibitors.
- Low‐Dose Oral Versus Topical Minoxidil in Androgenetic Alopecia: A Randomized, Double‐Blind, Double‐Dummy Controlled Trial
- ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study
- Bicalutamide 25 mg associated with minoxidil 1 mg versus minoxidil 1 mg for female-pattern hair loss: A randomized double-blind clinical trial
- Efficacy and safety of topical GT20029 in male patients with androgenetic alopecia: a multicenter, randomized, double-blind, placebo-controlled phase 2 study
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Hepatotoxicity Secondary to A Drug to Lose Weight, "Orlistat": to take into Account as a Differential Diagnosis
- Hallmark evidence of lipopolysaccharide (LPS) tolerance in obese women with polycystic ovary syndrome (PCOS) - LPS-induced NFkB suppression in mononuclear cells (MNC) is linked to hyperandrogenism in PCOS
- Faculty Opinions recommendation of Screening for prostate cancer.
- Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
- Flutamide was more effective than finasteride for idiopathic hirsutism
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach